Lunai Bioworks (LNAI) Enterprise Value (2011 - 2026)
Lunai Bioworks (LNAI) posted quarterly Enterprise Value of -$3.2 million for Q1 2026, down 93.19% year-over-year from -$46.3 million in Q1 2025, and down 541.78% quarter-over-quarter from -$491645.0 in Q4 2025.
Lunai Bioworks (LNAI) Enterprise Value (2011 - 2026) Analysis & Trends
Lunai Bioworks' Enterprise Value history runs 16 years deep, the most recent figure standing at -$3.2 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 93.19% year-over-year to -$3.2 million; the TTM figure through Mar 2026 stood at -$3.2 million (down 93.19% YoY), while the FY2025 annual figure was -$480551.0, down 117.97% from the prior year.
- Enterprise Value for Q1 2026 stood at -$3.2 million, down from -$491645.0 in the prior quarter.
- The five-year high for Enterprise Value was -$220467.0 in Q2 2024, with the low at -$11.2 million in Q1 2022.
- The 5-year median for Enterprise Value is -$624808.0 (2025), against an average of -$2.7 million.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value jumped 94.08% in 2023, then slumped 422.32% in 2025.
- Lunai Bioworks' Enterprise Value stood at -$4.1 million in 2022, then surged by 94.08% to -$243980.0 in 2023, then decreased by 27.78% to -$311764.0 in 2024, then plunged by 57.7% to -$491645.0 in 2025, then plunged by 541.78% to -$3.2 million in 2026.
- Business Quant data shows LNAI's Enterprise Value at -$3.2 million in Q1 2026, -$491645.0 in Q4 2025, and -$624808.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 | -3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.16 Mn |
| Dec 31, 2025 | -491,645.00 |
| Sep 30, 2025 | -624,808.00 |
| Jun 30, 2025 | -480,551.00 |
| Mar 31, 2025 | -1.63 Mn |
| Dec 31, 2024 | -311,764.00 |
| Sep 30, 2024 | -220,571.00 |
| Jun 30, 2024 | -220,467.00 |
| Mar 31, 2024 | -312,697.00 |
| Dec 31, 2023 | -243,980.00 |
| Sep 30, 2023 | -523,474.00 |
| Jun 30, 2023 | -1.87 Mn |
| Mar 31, 2023 | -2.95 Mn |
| Dec 31, 2022 | -4.12 Mn |
| Sep 30, 2022 | -7.97 Mn |
| Jun 30, 2022 | -9.17 Mn |
| Mar 31, 2022 | -11.15 Mn |
| Dec 31, 2021 | -13.71 Mn |
| Sep 30, 2021 | -15.38 Mn |
| Jun 30, 2021 | -20.66 Mn |